We found that coptisine repressed renal fibrosis induced by diabetes through suppressing the NLRP3 inflammasome, indicating that coptisine may become a promising drug for the treatment of diabetic nephropathy. This evidence concerns the gene NLRP3 and diabetes mellitus.